Pier Franco Conte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pier franco conte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pier Franco Conte Today - Breaking & Trending Today

ASCO 2023: Treatment De-Escalation and the Role of Age in HER2+ Breast Cancer

Studies presented at ASCO 2023 answered questions about de-escalating treatment and how age impacts outcomes in HER2+ breast cancer. ....

Vanderbilt University , United States , Comunidad Autonoma De Cataluna , Justinm Balko , Javier Cort , Franco Conte , International Breast Cancer Center , Vanderbilt University Medical Center , Veneto Institute Of Oncology , University Of Padua , One Year , Trastuzumab Remains , Pier Franco Conte , Veneto Institute , Identifying Patients Who Can Forgo ,

One Year of Adjuvant Trastuzumab Remains Standard in HER2+ Early Breast Cancer

Ten-year data from the Short-HER trial suggest that 1 year of adjuvant trastuzumab should remain standard care for HER2+ early breast cancer. ....

Franco Conte , Veneto Institute Of Oncology , University Of Padua , Pier Franco Conte , Veneto Institute ,

One Year of Adjuvant Trastuzumab Remains Standard in HER2+ Early Breast Cancer

Ten-year data from the Short-HER trial suggest that 1 year of adjuvant trastuzumab should remain standard care for HER2+ early breast cancer. ....

Franco Conte , Veneto Institute Of Oncology , University Of Padua , Pier Franco Conte , Veneto Institute ,